Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM [NA]

View source ↗

Summary

This clinical trial entry notes a study investigating how a gene polymorphism relates to susceptibility to Type 2 Diabetes Mellitus and how Chinese patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Type 2 Diabetes Mellitus, Susceptibility, Genetic | NA | Status: RECRUITING